Overview and Methodology of the National HIV Behavioral Surveillance Among Transgender Women - Seven Urban Areas, United States, 2019-2020.

Q1 Medicine
Dafna Kanny, Kathryn Lee, Evelyn Olansky, Taylor Robbins, Lindsay Trujillo, Teresa Finlayson, Elana Morris, Christine Agnew-Brune, Susan Cha, Johanna Chapin-Bardales, Cyprian Wejnert
{"title":"Overview and Methodology of the National HIV Behavioral Surveillance Among Transgender Women - Seven Urban Areas, United States, 2019-2020.","authors":"Dafna Kanny, Kathryn Lee, Evelyn Olansky, Taylor Robbins, Lindsay Trujillo, Teresa Finlayson, Elana Morris, Christine Agnew-Brune, Susan Cha, Johanna Chapin-Bardales, Cyprian Wejnert","doi":"10.15585/mmwr.su7301a1","DOIUrl":null,"url":null,"abstract":"<p><p>Transgender women, especially transgender women of color, are disproportionately affected by HIV. However, no surveillance system collects data on HIV risk factors among this population. To address this gap, CDC developed a surveillance system entitled National HIV Behavioral Surveillance Among Transgender Women (NHBS-Trans) to assess behavioral and contextual data through systematic biobehavioral surveillance to monitor behavioral risk factors, prevention usage, and HIV prevalence among transgender women. NHBS-Trans used respondent-driven sampling in seven urban areas in the United States. Trained interviewers used a standardized, anonymous questionnaire to collect information on HIV-related behavioral risk factors, HIV testing, and use of prevention services. Each of the seven participating project areas recruited approximately 200 eligible transgender women and offered anonymous HIV testing. Overall, in the seven project areas, 1,757 participants completed the eligibility screener for NHBS-Trans during 2019-2020; of these, 6.6% were seeds (i.e., a limited number of initial participants who were chosen by referrals from persons and community-based organizations who knew or were part of the local population of transgender women). A total of 1,637 (93.2%) participants were eligible, consented, and completed the interview. Of these, 1,624 (99.2%) agreed to HIV testing. Of the total 1,637 participants, 29 participants did not report identity of woman or transgender woman, resulting in a final sample of 1,608 transgender women. NHBS-Trans project area staff members (n = 14) reported that the survey was timely and addressed a critical need for HIV surveillance in a population that is often overlooked. The MMWR supplement includes this overview report on NHBS-Trans, which describes the methods (history, participant eligibility criteria, questionnaire, data collection, and HIV testing) as well as evaluation of project implementation and the performance of the questionnaire content, specifically the acceptability for transgender women. The other NHBS-Trans reports in the supplement include information on pre-exposure prophylaxis use, psychosocial syndemic conditions and condomless anal intercourse, nonprescription hormone use, homelessness, discrimination and the association between employment discrimination and health care access and use, and social support and the association between certain types of violence and harassment (gender-based verbal and physical abuse or harassment, physical intimate partner abuse or harassment, and sexual violence) and suicidal ideation. NHBS-Trans provides important data related to the goals of the Ending the HIV Epidemic in the U.S. initiative. Findings from NHBS-Trans can help guide community leaders, clinicians, and public health officials in improving access to and use of HIV prevention and treatment services by transgender women.</p>","PeriodicalId":37858,"journal":{"name":"MMWR supplements","volume":"73 1","pages":"1-8"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10826683/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"MMWR supplements","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15585/mmwr.su7301a1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Transgender women, especially transgender women of color, are disproportionately affected by HIV. However, no surveillance system collects data on HIV risk factors among this population. To address this gap, CDC developed a surveillance system entitled National HIV Behavioral Surveillance Among Transgender Women (NHBS-Trans) to assess behavioral and contextual data through systematic biobehavioral surveillance to monitor behavioral risk factors, prevention usage, and HIV prevalence among transgender women. NHBS-Trans used respondent-driven sampling in seven urban areas in the United States. Trained interviewers used a standardized, anonymous questionnaire to collect information on HIV-related behavioral risk factors, HIV testing, and use of prevention services. Each of the seven participating project areas recruited approximately 200 eligible transgender women and offered anonymous HIV testing. Overall, in the seven project areas, 1,757 participants completed the eligibility screener for NHBS-Trans during 2019-2020; of these, 6.6% were seeds (i.e., a limited number of initial participants who were chosen by referrals from persons and community-based organizations who knew or were part of the local population of transgender women). A total of 1,637 (93.2%) participants were eligible, consented, and completed the interview. Of these, 1,624 (99.2%) agreed to HIV testing. Of the total 1,637 participants, 29 participants did not report identity of woman or transgender woman, resulting in a final sample of 1,608 transgender women. NHBS-Trans project area staff members (n = 14) reported that the survey was timely and addressed a critical need for HIV surveillance in a population that is often overlooked. The MMWR supplement includes this overview report on NHBS-Trans, which describes the methods (history, participant eligibility criteria, questionnaire, data collection, and HIV testing) as well as evaluation of project implementation and the performance of the questionnaire content, specifically the acceptability for transgender women. The other NHBS-Trans reports in the supplement include information on pre-exposure prophylaxis use, psychosocial syndemic conditions and condomless anal intercourse, nonprescription hormone use, homelessness, discrimination and the association between employment discrimination and health care access and use, and social support and the association between certain types of violence and harassment (gender-based verbal and physical abuse or harassment, physical intimate partner abuse or harassment, and sexual violence) and suicidal ideation. NHBS-Trans provides important data related to the goals of the Ending the HIV Epidemic in the U.S. initiative. Findings from NHBS-Trans can help guide community leaders, clinicians, and public health officials in improving access to and use of HIV prevention and treatment services by transgender women.

2019-2020年美国变性女性--七个城市地区全国艾滋病毒行为监测概述和方法。
变性妇女,尤其是有色人种变性妇女,受艾滋病毒的影响尤为严重。然而,没有任何监测系统收集有关这一人群中艾滋病毒风险因素的数据。为了填补这一空白,美国疾病预防控制中心开发了一个名为 "变性女性全国 HIV 行为监测"(NHBS-Trans)的监测系统,通过系统的生物行为监测来评估行为和背景数据,以监测变性女性的行为风险因素、预防使用情况和 HIV 感染率。NHBS-Trans 在美国七个城市地区采用受访者驱动的抽样调查。经过培训的访谈者使用标准化的匿名问卷收集与 HIV 相关的行为风险因素、HIV 检测和预防服务使用情况等信息。七个参与项目的地区各招募了约 200 名符合条件的变性女性,并提供匿名 HIV 检测。总体而言,在 2019-2020 年期间,七个项目地区共有 1,757 名参与者完成了 NHBS-Trans 的资格筛选;其中 6.6% 为种子选手(即通过认识或属于当地变性女性人群的个人和社区组织的推荐而选出的数量有限的初始参与者)。共有 1637 名(93.2%)参与者符合条件、同意并完成了访谈。其中,1624 人(99.2%)同意进行 HIV 检测。在总共 1637 名参与者中,有 29 名参与者没有报告女性或变性女性的身份,因此最终的样本为 1608 名变性女性。NHBS-Trans 项目区的工作人员(n = 14)表示,这项调查非常及时,满足了对经常被忽视的人群进行 HIV 监测的关键需求。MMWR 增补包括这份关于 NHBS-Trans 的概述报告,其中介绍了调查方法(历史、参与者资格标准、问卷、数据收集和 HIV 检测),以及对项目实施和问卷内容表现的评估,特别是变性妇女的接受程度。补充报告中的其他 NHBS-Trans 报告包括以下方面的信息:暴露前预防措施的使用、社会心理综合症和无套肛交、非处方激素的使用、无家可归、歧视以及就业歧视与医疗保健的获取和使用之间的关联、社会支持以及某些类型的暴力和骚扰(基于性别的言语和身体虐待或骚扰、亲密伴侣的身体虐待或骚扰以及性暴力)与自杀意念之间的关联。NHBS-Trans 提供了与 "结束美国 HIV 流行 "倡议目标相关的重要数据。NHBS-Trans 的研究结果可以帮助指导社区领袖、临床医生和公共卫生官员改善变性女性获得和使用 HIV 预防和治疗服务的情况。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
MMWR supplements
MMWR supplements Medicine-Medicine (all)
CiteScore
48.60
自引率
0.00%
发文量
8
期刊介绍: The Morbidity and Mortality Weekly Report (MMWR ) series is prepared by the Centers for Disease Control and Prevention (CDC). Often called “the voice of CDC,” the MMWR series is the agency’s primary vehicle for scientific publication of timely, reliable, authoritative, accurate, objective, and useful public health information and recommendations. MMWR readership predominantly consists of physicians, nurses, public health practitioners, epidemiologists and other scientists, researchers, educators, and laboratorians.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信